🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To provide expanded access of esmethadone (REL-1017) to patients with a ser...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT06009003
Treatments Being Tested
This is an outpatient, 2-arm, Phase 3, multicenter, randomized, double-blin...
Status
Completed
Location
Relmada Site
Start Date
2021-06-02
Trial ID
NCT05081167
This study evaluated the safety, tolerance, and pharmacokinetics (PK) of d-...
Status
Completed
Location
Multiple Locations
Start Date
2014-12-04
Trial ID
NCT03637361
This was a 1-year, multicenter, open-label, long-term study to assess the s...
Status
Completed
Location
Relmada Site
Start Date
2021-04-01
Trial ID
NCT04855760
Treatments Being Tested
This a Phase 2a, multicenter, randomized, double-blind, placebo controlled ...
Status
Completed
Location
Woodland International Research Group
Start Date
2018-05-11
Trial ID
NCT03051256
Proof of concept, double-blind, randomized, placebo-controlled trial with d...
Status
Suspended
Location
Sleep Center, IRCCS San Raffaele
Start Date
2022-10-22
Trial ID
NCT04145674
Treatments Being Tested
Study Overview This clinical trial is a Phase 3 research study designed to ...
Status
Withdrawn
Location
Mediolanum Cardio Research
Start Date
2024-12-27
Trial ID
NCT06735079
Treatments Being Tested
This study evaluated the safety, tolerance, and pharmacokinetics (PK) of d-...
Status
Completed
Location
Multiple Locations
Start Date
2015-08-31
Trial ID
NCT03638869
A Phase 3, randomized, double-blind, placebo-controlled, multicenter trial ...
Status
Terminated
Location
Relmada Site
Start Date
2023-08-17
Trial ID
NCT06011577
This is an outpatient, 2-arm, Phase 3, multicenter, randomized, double-blin...
Status
Terminated
Location
Relmada Site
Start Date
2021-03-30
Trial ID
NCT04855747